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S-seco-porphyrazine as a new member of the seco-porphyrazine family –
Synthesis, characterization and photocytotoxicity against cancer cells
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An important subgroup within the porphyrazine (Pz) family constitutes seco-porphyrazines, in the chemical
structure of which one pyrrole unit is opened in the oxidative process. So far, there are only limited data on N-secoand C-seco-Pzs. Here, the synthesis of a novel member of the Pzs seco-family, represented by an S-seco-tribenzoporphyrazine analogue, 22,23-bis(4-(3,5-dibutoxycarbonylphenoxy)butylsulfanyl)tribenzo[b,g,l]-22,23-dioxo22,23-seco-porphyrazinato magnesium(II), is reported, with moderate 34% yield. The new derivative was characterized using NMR spectroscopy, UV–Vis spectroscopy, and mass spectrometry. In the photochemical study
performed following the indirect chemical method with 1,3-diphenylisobenzofuran, S-seco-Pz revealed a high
singlet oxygen quantum yield of 0.27 in DMF.
Potential photocytotoxicity of S-seco-Pz was assessed in vitro on three cancer cell lines – two oral squamous
cell carcinoma cell lines derived from the tongue (CAL 27, HSC-3) and human cervical epithelial adenocarcinoma cells (HeLa). In the biological study, the macrocycle was tested in its free form and after loading into
liposomes. It is worth noting that S-seco-Pz was found to be non-toxic in the dark, with cell viability levels over
80%. The photocytotoxic IC50 values for free S-seco-Pz were 0.61, 0.18, and 4.1 µM for CAL 27, HSC-3 and HeLa
cells, respectively. Four different liposomal compositions were analyzed, and the cationic liposomes revealed the
highest photokilling efficacy, with the IC50 values for CAL 27, HSC-3, and HeLa cells at 0.24, 0.25, and 0.31 µM,
respectively. The results of the photocytotoxicity study indicate that the new S-seco-tribenzoporphyrazine can be
considered as a potential photosensitizer in photodynamic therapy of cancer, along with the developed cationic
liposomal nanocarrier.

1. Introduction
Porphyrazines (Pzs) constitute a distinct group of porphyrinoid
macrocycles and are often considered as synthetic analogues of porphyrins that exist in nature. They have gained increasing attention due
to remarkable optical and electrochemical properties, which make them
potential catalysts or materials for chemistry and technology, as well as
photosensitizers for photodynamic therapy in medicine [1–3]. Light in
the region 600–800 nm penetrates deeply human tissues and can initiate a photodynamic reaction in the presence of molecular oxygen and

photosensitizer, leading to the generation of reactive oxygen species
that are essential for photodynamic therapy [4–6].
Seco-porphyrazines (seco-Pzs) have gained much attention since
their first synthesis by the laboratories of Professors A.G.M. Barrett and
B.M. Hoffman in 1994 [7]. These compounds attracted interest because
of their optical properties and high singlet oxygen generation quantum
yields (up to 0.74) [8]. It is notable that when one pyrrole unit of the
porphyrazine is opened in an oxidative process, giving access to its secoporphyrazine derivative, singlet oxygen generation may increase. There
are only a few seco-porphyrazines described in the literature, among
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2. Results and discussion

them N-seco-porphyrazines [7–15] and C-seco-porphyrazines [16–21],
synthesized from diaminomaleonitrile and maleonitrile, respectively.
Worth mentioning are also three-quarter Pzs, technically accounted as
seco-Pzs, in which one of the pyrrole rings is not formed at all during
synthesis; therefore, we would suggest calling them – sine-Pzs (sine –
Lat. without) [22,23]. Moreover, quite structurally close derivatives are
Pzs in which at least one of the pyrrole β-carbons is lost during macrocyclic pyrrole oxidation [24]. It seems that the low number of secoPzs published so far may be attributed to their limited stability and/or
the oxidation feasibility of pyrrolic rings. Another aspect might be related to their difficult isolation and low reaction yields during their
formation (even 0.3%) [23]. In addition, the mechanistic aspects of
their synthesis have not been fully explained at the experimental level.
Not much is also known about the reactivity of seco-porphyrazines.
Their high photoactivity has been analyzed so far in photocatalytic
oxidation, the cycloaddition of oxygen to 1,3-dienes [25] on a polymeric solid support [14]. In addition, Prof. P.A. Stuzhin, in a study
published with A.V. Kozlov, presented the transformation of N-seco-Pz
towards a novel porphyrinoid, named pyraziniporphyrazine, in which
pyrrole was expanded to a pyrazine ring [10]. Interestingly, methodologies developed in Professors A.G.M. Barrett and B.M. Hoffman
groups by Montalban et al. and Sakellariou et al. allowed the further
oxidation of seco-porphyrazines to diseco-porphyrazines, with the trans
isomer reported to be stable long enough that it could be isolated
[12,15]. Moreover, Gonca presented interesting 4-biphenylyl C-seco-Pz
complexes in the free form and after metallation with Fe(III), which
gave further access to monomacrocyclic complexes with pyridine or
polymacrocyclic complexes with pyrazine [19,21].
Porphyrazines substituted with sulfanyl moieties have also been
studied widely. They can be modified, have interesting optical [26,27]
and electrochemical properties [28–30], and have the potential to be
used in photodynamic therapy (PDT) [31,32] and wastewater treatment
[33–35]. Although sulfanyl porphyrazines have been synthesized for
over twenty years, S-seco-porphyrazine has never been reported and
characterized so far [36]. Nevertheless, it should be pointed out that in
1992 Velázquez et al. reported the formation of porphyrazine-like
macrocyclic compounds during the synthesis of sulfanyl porphyrazines,
but unfortunately, they did not manage to isolate and characterize them
[37].
Now, we report the first S-seco-Pz synthesis. The macrocycle was
characterized using one and two-dimensional NMR techniques, UV–Vis
spectroscopy, and mass spectrometry. After the quantum yield of singlet
oxygen generation was established, the photocytotoxicity of seco-porphyrazine was evaluated in vitro against oral squamous cell carcinoma
cell lines derived from the tongue (CAL 27, HSC-3) and human cervical
epithelial adenocarcinoma cells (HeLa).

2.1. Synthesis and identification
Attempts to cleave the ester groups present in tribenzoporphyrazine
1 following phase transfer conditions in a two-phase mixture of aqueous
sodium hydroxide solution and dichloromethane led to a limited
amount of a new blue product 2, which was more polar than 1 in TLC
chromatography, using dichloromethane/methanol mixtures (Scheme
1). The new molecule was soluble in chloroform, dichloromethane,
tetrahydrofuran, toluene, N,N-dimethylformamide (DMF), dimethylsulfoxide (DMSO) and acetone, but was insoluble in n-hexane,
methanol, and water. The UV–Vis spectrum of 2 was different from that
observed for substrate 1 (Fig. 2). The split in the Q-band absorption of
Pzs is the result of the loss of symmetry during demetallation, or, less
commonly, the modification of the macrocyclic ring structure [1,3,38].
Moreover, MS ESI results indicated the formation of the oxidation
product, as the monoisotopic mass signal of 1 increased by the mass of
dioxygen (m/z found: 1279.368, [M+H]+, C68H71MgN8O12S2 requires
1279.448). A combination of these two measurements suggests the
oxidative breaking of the pyrrole ring and S-seco-porphyrazine formation (Scheme 1).
The yield of the above-discussed reaction was very low (< 5%).
Therefore, suspecting seco-Pz formation, known literature approaches
developed so far for the synthesis of seco-Pzs were studied for scaling-up
the synthesis from 1 to 2. The literature survey indicated that seco-Pz
formation has been achieved as the result of the following processes: (i)
in the macrocyclization reaction as a byproduct [15,22,23]; (ii) after
the oxidation reaction using: (a) KMnO4 [8,11,15], (b) MnO2 [15], (c)
gaseous oxygen [10], and (d) oxygen from air [12–14]; (iii) in the demetallation reaction with acetic or trifluoroacetic acid in an air atmosphere [7,15,17,18] or in an inert gas atmosphere [16–18,20,21]; (iv)
serendipitously in non-specific reactions – loss of both β-carbons of one
pyrrole during attempted metallation of β,β-dihydroxyporphyrazine
derivative with nickel(II) [24], or in a specific one-pot reaction leading
to multi-gram yields of a water-soluble N-seco-Pz [9].
Attempts to find suitable conditions for the synthesis of the desired
S-seco-Pz 2, taking into account the reaction conditions given above, led
to interesting observations. The oxidation reaction of 1 with MnO2 in
dichloromethane or 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (following conditions given in Ref. [39]) did not lead to any seco-product at
all, and enabled the isolation of only the unreacted substrate. Once the
substrate was treated with trifluoroacetic acid, only demetallated Pz 3
was isolated. Finally, the biphasic system consisting of the aqueous
solution of KMnO4 and dichloromethane led to 2 in moderate 34% yield
(Scheme 1).

Scheme 1. Reactivity of 1: (i) KMnO4, H2O/dichloromethane 1:1 (v/v), 2 h, room temperature; (ii) trifluoroacetic acid, 15 min., room temperature, air.
2
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were found in the 1H-13C HMBC spectrum, unlike the adjacent peak at
167.36 ppm assigned to isophthalate carbonyl groups, which allowed
correct identification of these two signals (see Figs. S01 and S02 in the
Supplementary Information for the 1H and 13C NMR spectra, respectively).
As we mentioned before, the initial MS ESI results indicated the
formation of the oxidation product, as the monoisotopic mass signal of
1 increased by the mass of dioxygen. This result was confirmed in another MS study using the MS MALDI TOF technique (m/z found:
1279.3926, [M+H]+, C68H71MgN8O12S2 requires 1279.4483).
Analysis of the Pz 2 MS MALDI spectrum, accompanied by the linked
scan technique revealed a series of fragmentation signals that confirmed the structure of seco-porphyrazine. The most significant signal at
m/z 517.143 corresponds to the fragmentation ion formed by the break
of both bonds between seco-carbonyl carbons and sulfur atoms (see
Supplementary Information). The formation of such species was possible only when the oxidation of the pyrrole carbons to the seco-carbonyl groups had occurred. Additionally, the mass spectrum revealed a
series of m/z fragmentation peaks confirming the structure of S-secotribenzoporphyrazine 2 (for the MS spectra see Figs. S06–S09 in the
Supplementary Information).

Initially, we attempted to obtain 2 in its crystal form. When all attempts to obtain the single crystal suitable for crystallographic measurements failed, the structure was analyzed with the use of NMR
spectroscopy and MS spectrometry. Therefore, a series of 1D (1H, 13C)
and 2D (1H-1H COSY, 1H-1H TOCSY, 1H-1H NOESY, 1H-13C HSQC and
1
H-13C HMBC) accompanied by 1D 1H temperature spectra ranging
from –15 to 55 °C, were recorded.
These experiments were conducted mainly for Pz 2 structure verification, but initially due to obtaining far more complex spectra than
expected, it was necessary to examine whether the macrocycle 2 in
pyridine‑d5 solution exists in its free form only or is involved in
stacking or aggregation. The NMR data obtained in pyridine‑d5 revealed that Pz 2 is not aggregated during the measurement as no
significant differences were observed in the temperature spectra. Also,
experiments in DMSO‑d6 or CDCl3 with the addition of CF3COOD did
not lead to spectra with better spectral quality. In addition, NMR data
revealed that the proton (and carbon) signals assigned to each of the
3,5-dibutoxycarbonylphenoxy substituents appear at similar but
slightly shifted values at 0.76, 1.19, 1.42, 4.12, 8.03, 7.86 ppm, and
0.85, 1.34, 1.61, 4.32, 8.26, 8.51 ppm, respectively (see Fig. 1). The
resonances of non-terminal protons belonging to both substituents
and present in the butyl linker appeared at 1.31–1.22 ppm. Trying
to explain these phenomena, we analyzed the 1H, 13C NMR spectroscopy and X-ray data presented by Montalban et al. for 2,3,
7,8,12,13,17,18-octakis(dimethylamino)-2-seco-porphyrazine-2,3dione, [2,3-bis(dimethylamino)-7,8,12,13,17,18-hexapropyl-2-seco2,3-dioxoporphyrazinato]zinc(II), as well as the 1H, 13C NMR spectroscopy data of [2,3,7,8,12,13,17,18-octakis(dimethylamino)-2,12diseco-2,3,12,13-tetraoxoporphyrazinato)zinc(II) [15]. According to
the NMR data that have been presented for these three macrocycles, it
could be concluded that the seco-substituents undergo rotation,
causing the signals belonging to both substituents to appear separately. Characteristic for seco-carbonyl carbon resonance, the presence
of which proves the opening of the pyrrole ring in the 13C NMR
spectrum, was observed at 167.96 ppm. No correlations of this signal
with any of the isophthalate nor aliphatic ester proton resonances

2.2. Photophysical characterization
The B-band and the Q-band are the characteristic absorption bands
in the UV–Vis spectra of porphyrazine compounds [40]. Seco-Pz is a
compound composed of three pyrrole rings linked together to form a
macrocyclic ring, which results in significant differences in the Q-band
absorption of seco-Pz (2) in comparison to the parent porphyrazine 1
[1]. The Q-band split in the recorded absorption spectrum was also
observed for demetallated Pz 3, but to a lesser extent than for 2. The
decrease in symmetry and the resulting Q-band splitting in the spectra
of both molecules 2 and 3 were, however, caused by different factors. In
the case of 2 it was an effect of the oxidation of one pyrrole ring within
the macrocycle, whereas for 3 it was a result of demetallation.
The ability to generate singlet oxygen by the seco-Pz 2 was assessed
using the indirect chemical method with DPBF and ZnPc as a reference.
The results of this photochemical experiment revealed that 2 is a
moderate singlet oxygen generator with the quantum yield of singlet
oxygen generation equal to 0.27 in DMF. Macrocycle 1 under the same
conditions had a quantum yield of only 0.05 [41]. Therefore, the pyrrole ring-opening caused a five-fold increase of the singlet oxygen
quantum yield.

Fig. 1. 1H and (13C) chemical shift values [ppm] of Pz 2. Selected 1H-1H COSY
and 1H-13C HMBC correlations are marked with bold lines and dashed arrows,
respectively. The 13C chemical shift values are presented with two decimal
places.

Fig. 2. UV–Vis spectra of 1 (dashed line), 2 (solid line), and 3 (dotted line). All
spectra were recorded in dichloromethane and are normalized.

3
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Fig. 3. Light toxicity (cell viability as % of untreated controls) and dark control (cell viability as % of untreated controls) of 2 against CAL 27, HSC-3 and HeLa cells.
Data represent the mean ± standard deviation obtained from experiments performed in triplicate. Statistical significance is indicated with asterisks: *p < 0.05,
**p < 0.01, ***p < 0.001.

2.3. Biological activity against cancer cell lines
The potential application of 2 in the photodynamic therapy of
cancer was evaluated by in vitro examination of its photocytotoxicity on
two oral squamous cell carcinoma cell lines derived from the tongue
(CAL 27, HSC-3) and human cervical epithelial adenocarcinoma cells
(HeLa). Firstly, the dark toxicity of 2 was tested at the concentrations of
0.1, 1.0, and 10 µM. There was no significant dark toxicity to the oral
cancer cells. However, some cytotoxicity on cervical epithelial adenocarcinoma cells was found at 1.0 and 10 µM, but the reduction in cell
viability did not exceed 20% (Fig. 3 and Table S03 in the
Supplementary Information). Thus, the light-induced toxicity was examined at the same concentrations. After 24 h of incubation with 2
dissolved in medium with 0.25% DMSO, cancer cells were exposed to
light of 690 nm from a High Power LED Multi-Chip Emitter (Roithner
Lasertechnik GmbH) for 20 min. On the next day, the cell viability was
quantified by the Alamar Blue assay. It was found that at 0.1 µM seco-Pz
2, CAL 27 and HSC-3 cell viability was reduced by about 30%, while
there was no cytotoxicity to HeLa cells. Seco-Pz 2 at 1.0 µM had considerable photocytotoxicity to CAL 27 and HSC-3 cells, with reduction
in viability of 74% and 94%, respectively, but HeLa cell viability was
reduced by only 22%. At the highest concentration (10 µM), photocytotoxicity of more than 90% was observed in all three cell lines tested
(Fig. 3 and Table S03 in supplementary information).
Further studies were performed with liposomes to improve the
aqueous solubility of seco-Pz 2 and its delivery to cancer cells.
Liposomal nanoparticles have already been widely researched as a drug
delivery system for photosensitizers [42,43]. Tribenzoporphyrazine 2
was incorporated into four different liposomes comprising 1-palmitoyl2-oleoyl-sn-glycero-3-phosphocholine (POPC) or 1,2-dioleoyl-sn-glycero3-phosphoethanolamine (DOPE), with either a negative charge (by the
incorporation of L-α-phosphatidyl-DL-glycerol; PG) or a positive charge
(by the inclusion of 1,2-dioleoyl-3-trimethylammonium propane;
DOTAP). POPC is a phosphatidylcholine derivative with saturated
palmitoyl and monounsaturated oleoyl chains, whereas DOPE belongs
to phosphatidylethanolamines and possesses two unsaturated oleoyl
chains (Fig. 4). Noteworthy, phosphatidylcholine and phosphatidylethanolamine derivatives are the most common phospholipids building
mammalian cell membranes. Thus, lipid-based nanoparticles containing
PC and PE, including liposomes, exhibit high biocompatibility and
biodegradability, and are commonly used as carriers for the delivery of
various drugs [44,45].
Liposomes with 2 and free liposomes without photosensitizer (as
controls) were prepared by a thin-film hydration method and extruded
through polycarbonate membranes to produce a uniform size distribution [32,46]. The mean diameter of the extruded liposomes with 2
varied from 0.16 to 0.41 µm. The size of liposomes was strongly dependent on the adjuvant lipid providing the net surface charge.

Fig. 4. Structures of lipids used for liposome preparation.

Positively charged liposomes with DOTAP had a mean diameter of 0.40
and 0.41 µm for 2:DOTAP:POPC (0.1:2:8) and 2:DOTAP:DOPE
(0.1:2:8), respectively. By contrast, negatively charged liposomes with
PG were smaller, with the mean diameter of 0.16 µm for 2:PG:POPC
(0.1:2:8) and 0.18 µm for 2 PG:DOPE (0.1:2:8). Noteworthy, POPC or
DOPE, which constituted about 80% of the lipids in each liposomal
formulation, did not have such a strong influence on the size of the
liposomes, but POPC-containing particles were always a little smaller
than the corresponding DOPE liposomes (Table S04 in Supplementary
Information).
Liposomal formulations were examined at the same concentrations
as those of the free form 2 in solution (0.1, 1.0 and 10.0 µM, Fig. 5 and
Table S05 in Supplementary Information). Negatively charged
PG:POPC liposomes with incorporated 2 had a photocytotoxic effect on
all three cell lines only at 10 µM. The cell viability was reduced by
about 20% for CAL 27 and HeLa cells, but was reduced by 50% in the
case of HSC-3 cells. We should note that free Pz 2 was about 10-fold
more effective at this concentration, as well as at lower concentrations.
Thus, encapsulation in these particular liposomes was inhibitory to the
phototoxicity of Pz 2. This observation is in contrast to that described
earlier for the magnesium(II) diazepinotribenzoporphyrazine in Piskorz
et al. (2014) [47]. Therefore, optimal liposome compositions should be
explored for the encapsulation of novel photosensitizers.
Cationic 2:DOTAP:POPC particles showed higher activity. CAL 27
cell viability was reduced by 85% at the 1 µM concentration, and more
than 99% at 10 µM. The viability of HSC-3 and HeLa cells was affected
even at the lowest concentration (0.1 µM), by 22% and 26%
4
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Fig. 5. Light toxicity (cell viability as % of untreated controls) and dark control (cell viability as % of untreated controls) of 2 in various liposomes against CAL 27,
HSC-3 and HeLa cells. Data represent the mean ± standard deviation obtained from experiments performed in triplicate. Statistical significance is indicated with
asterisks: *p < 0.05, **p < 0.01, ***p < 0.001.

respectively. Photocytotoxicities of 93% for HSC-3 and 86% for HeLa
cells were found at 1 µM, whereas 10 µM 2 reduced HSC-3 and Hela cell
viability by more than 90%. Another liposome formulation that was
composed of 2, PG and DOPE, reduced CAL 27 cell viability by about
20% at 1 µM, and more than 40% at 10 µM. HSC-3 cells were more
sensitive, with the photocytotoxic effect of 2:PG:DOPE reaching 94%
and 97% at 1 and 10 µM, respectively. HeLa cell viability was affected
by 34% at 1 µM and 94% at 10 µM. Positively charged 2:DOTAP:DOPE
particles revealed a photocytotoxic effect at 1 and 10 µM only. HSC-3
and HeLa cell viabilities were reduced by almost 20% at 1 µM. At the
highest concentration (10 µM), photocytotoxicity to CAL 27 and HSC-3
cells exceeded 80%, whereas HeLa cell viability was reduced by only
45%. However, that concentration of 2:DOTAP:DOPE liposomes also
caused a significant dark cytotoxic effect on HSC-3 cells of about 35%
(Fig. 5 and Table S05 in supplementary information).
Further examination aimed to compare the photocytotoxicity of free
tribenzoporphyrazine 2 with that of the most effective liposomes
composed of 2, DOTAP and POPC. These experiments were performed
at six concentrations of 2, both free and incorporated into DOTAP:POPC
liposomes, to determine the correlation between the viability of the
cancer cells and the concentration of photosensitizer (Fig. 6 and Tables
S06, S07 in Supplementary Information). The calculated IC50 values are
presented in Table 1. S-seco-tribenzoprophyrazine 2 in its free form in
solution exhibited the highest photocytotoxicity against HSC-3 cells
with an IC50 value of 0.18 µM. By contrast, HeLa cells were the least
sensitive to treatment with 2 (IC50 = 4.1 µM). After incorporation of 2
into DOTAP:POPC liposomes, its effect on all three cell lines was similar, with IC50 values in the range of 0.24–0.31 µM. It should be noted
that liposomes enhanced the activity of 2 on HeLa cells more than 10
times, and on CAL 27 cells almost 3 times. The photocytotoxicity of
2:DOTAP:POPC liposomes on HSC-3 cells, however, was slightly worse
than those of the free form of 2 (Table 1).
Moreover, these results can be compared with the previous ones for
the precursor compound tribenzoporphyrazine 1, whose activity was
examined on CAL 27 and HSC-3 cells [41]. It is worth emphasizing that

Fig. 6. Photocytotoxic effect of 2 in free form and encapsulated in
DOTAP:POPC liposomes. Data represent the mean ± standard deviation for
experiments performed in triplicate. Note the different scales of the x-axis.

S-seco-tribenzoporphyrazine 2 was much more active on both cell lines
than tribenzoporphyrazine 1 with an IC50 value almost 11 times lower
for CAL 27 cells and almost 60 times lower for HSC-3 cells.
5
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800 spectrometer at 298 K unless stated otherwise. Chemical shifts (δ)
are reported in parts per million (ppm) and referenced to the residual
solvent peak (DMSO‑d6: δH = 2.50 ppm, δC = 39.5 ppm; pyridine‑d5:
δH = 8.74, 7.58, 7.22 ppm, δC = 150.35, 135.91, 123.87 ppm).
Coupling constants (J) are quoted in Hertz (Hz). The abbreviations s, d,
t, m, trbz refer to singlet, doublet, triplet, multiplet and tribenzoporphyrazine phenyl ring protons, respectively. 1H and 13C resonances
were assigned unambiguously based on 1H-1H COSY, 1H-13C HSQC, and
1
H-13C HMBC experiments. FT-IR spectra were recorded on Bruker IR
spectrometer, in the range 500–4000 cm−1 with KBr as a blank. Mass
spectra (HRMS ESI) were carried out by the Advanced Chemical
Equipment and Instrumentation Facility at the Faculty of Chemistry,
Wielkopolska Center for Advanced Technologies at Adam Mickiewicz
University in Poznan and Department of Inorganic and Analytical Chemistry
at Poznan University of Medical Sciences.
Tribenzoporphyrazine 1 was synthesized according to reference
[41].

Table 1
IC50 values [µM] for the cytotoxicity of 1 and 2, free and after incorporation in
DOTAP:POPC liposomes. Singlet oxygen generation quantum yields of 1 and 2.
Photosensitizer

1
1:DOTAP:POPC
2
2:DOTAP:POPC
a
b

Cell lines

ΦΔ (in DMF)

CAL 27

HSC-3

HeLa

6.66a
0.26b
0.61
0.24

10.6a
0.19b
0.18
0.25

–
0.29b
4.1
0.31

0.05a
–
0.27
–

Value from reference [41].
Value from reference [32].

Interestingly, after incorporation of 1 into DOTAP:POPC liposomes, the
IC50 values were in the range of 0.19–0.29 µM and were similar to those
obtained for 2:DOTAP:POPC (0.24–0.31 µM, Table 1). However, the
best results both for the free form and liposomal formulations, with IC50
values in the range 0.007–0.042 µM, have been previously found for
22,23-bis{4-[3,5-di(hydroxymethyl)phenoxy]butylsulfanyl}tribenzo
[b,g,l]porphyrazinato magnesium(II), which formally is the derivative
of 1 subjected to the reduction reaction, and thus equipped with the
terminal hydroxymethyl groups [32,41].
The photocytotoxicity of other photosensitizers has also been assessed on CAL 27, HSC-3 and HeLa cell lines. Clinically approved 5-ALA
(5-aminolevulinic acid) is enzymatically, intracellularly, converted to
Protoporphyrin IX, which was found active in vitro against CAL 27 cells
with IC50 values equal to 620 µM after irradiation for 50 s with 635 nm
light (~18 mW/cm2, 10 J/cm2) [48]. Another popular photosensitizer,
Chlorin e6, was found to act efficiently on the CAL 27 cell line with IC50
value equal to 1.06 µM after irradiation with a 0.5 J/cm2 dose of
665 nm light [49]. The clinically relevant compound, porfimer sodium,
better known in clinical practice as Photofrin®, was tested on HeLa
cells. In the experiments, the IC50 values reached for Photofrin® were
2.57 µM when a light-dose of 5 J/cm2 was used [50]. Lapshina et al.
studied the photocytotoxicity of poly(N-vinylpyrrolidone) solutions of
substituted phthalocyanines in HeLa human adenocarcinoma cells,
which was characterized by the IC50 values of up to 1.83 µM after irradiation with a 8 mW/cm2 dose of 670 nm light for 30 min [51].
Boron-dipyrromethenes (BODIPY) are gaining nowadays more attention in the photosensitizer field. One such molecule, comprising of
oxovanadium(IV) complex bound to a boron-dipyrromethene moiety,
was tested on HeLa cells, yielding IC50 equal to 0.15 µM when light
from the range of 400–700 nm with 10 J/cm2 dose for 1 h was applied
[52]. Other significant results found in reviews (i.e. [53]) indicate that,
although, it seems problematic to compare the results obtained at
various light dosimetry parameters, the potential value of liposomal
formulations of 1 and 2 for further photocytotoxicity studies towards
photodynamic therapy, is high.

3.2. Synthesis
3.2.1. 22,23-Bis(4-(3,5-dibutoxycarbonylphenoxy)butylsulfanyl)tribenzo[b,g,l]-22,23-dioxo-22,23-seco-porphyrazinato magnesium(II) (2)
The synthetic method was adapted from [15]. Tribenzoporphyrazine 1 (42 mg, 0.034 mmol) was dissolved in CH2Cl2 (30 mL) in a
round-bottom flask open to the air. A solution of KMnO4 (6 mg,
0.038 mmol in 30 mL of water) was added and the reaction mixture was
stirred vigorously in the dark for 2 h. After that, the organic layer was
separated in a separatory funnel. CH2Cl2 was evaporated under reduced
pressure, and the blue residue was chromatographed on silica gel, using
CH2Cl2, and later, CH2Cl2:methanol 20:1 (v/v) as eluents to give 2 in
the form of a blue film (14.5 mg, 34% yield). M.p. 151–153 °C. Rf
(CH2Cl2/methanol 20:1 v/v) 0.12. UV–Vis (CHCl3): λmax, nm (logε) 319
(4.88), 337 (4.89), 369 (4.83), 621 (4.61), 670 (4.54), 727 (4.97). 1H
NMR (800 MHz, pyridine‑d5): δ 9.68–9.54 (m, 5H, trbz-H), 8.66–7.72
(m, 13H, trbz-H, isophthal-H), 4.40–4.29, 4.14–4.07 (2 × m, 12H,
2 × CH2O), 2.37–2.01 (m, 4H, SCH2), 1.61, 1.42 (2 × m, 8H,
2 × CH2CH2CH3), 1.34, 1.19 (2 × m, 8H, 2 × CH2CH2CH3), 1.31–1.22
(m, 8H, SCH2CH2CH2), 0.85, 0.76 (2 × t, J = 7 Hz, 12H, 2 × CH3); 13C
NMR (201 MHz, pyridine‑d5): δ 168.0, 167.4, 161.9, 152.6, 143.1,
143.0, 142.1, 138.2, 135.0, 133.6, 133.2, 126.5, 126.2, 125.4, 125.2,
124.6, 122.2, 121.1, 67.8, 67.5, 34.5, 33.9, 33.3, 33.1, 21.8, 21.7, 21.7,
16.2, 16.2. FT-IR (KBr, νmax/cm−1): 2943, 2924, 2850, 1724, 1684,
1558, 1522, 1506, 1458, 1310, 1306, 1238, 932. HRMS (ESI) m/z
found: 1279.3926, [M+H]+, C68H71MgN8O12S2 requires 1279.4483;
1317.3404, [M+K]+ C68H70MgN8O12S2K requires 1317.4042;
2596.7021, [2M+K]+ C136H140Mg2N16O24S4K requires 2595.8447.
HPLC purity is provided in the supplementary information.
3.2.2. 22,23-Bis[4-(3,5-dibutoxycarbonylphenoxy)butylsulfanyl]tribenzo[b,g,l]porphyrazine (3)
Pz 1 (66 mg, 0.053 mmol) was suspended in 3 mL of trifluoroacetic
acid in a round bottomed flask. Reaction mixture was stirred in the dark
for 15 min in air. Afterwards, reaction mixture was poured on ice and
neutralized with NaHCO3. Blue product was extracted with dichloromethane. Organic layer was collected and the solvent was evaporated to dryness giving solid residue, which was purified by means of
column chromatography using silica gel and eluents CH2Cl2, later
CH2Cl2:methanol 100:1 to 50:1 (v/v) to give 30.5 mg of deep blue film
identified as 3 (yield 47%). M.p. 137–139 °C. Rf (CH2Cl2) 0.29. UV–Vis
(CH2Cl2): λmax, nm (logε) 319 (4.02), 338 (4.05), 614 (3.90), 704
(4.13). 1H NMR (800 MHz, pyridine‑d5) δ 9.26 (s, 2H, trbz), 9.16 (s, 2H,
trbz), 9.07 (d, J = 5.5 Hz, 1H, trbz), 9.02 (d, J = 5.5 Hz, 1H, trbz), 8.62
(m, 2H, 4′ isophthalate), 8.24 (m, 2H, trbz), 8.09 (m, 4H, trbz), 8.02 (m,
4H, 2′(6′) isophthalate), 4.39 (m, 8H, eCOOCH2e), 4.11 (m, 4H,
AreOeCH2), 3.94 (m, 4H, SeCH2), 2.06 (m, 4H, SeCH2eCH2eCH2),
1.92 (m, 4H, SeCH2eCH2), 1.66 (m, 8H, eCH2eCH2eCH3), 1.38 (m,

3. Experimental
3.1. Materials and instruments
All reactions were conducted in oven-dried glassware under an
argon atmosphere using Radleys Heat-On™ heating system. Solvents and
all reagents were obtained from commercial suppliers and used without
further purification, except for dichloromethane, which was freshly
distilled before use. All solvents were removed by rotary evaporation at
or below 50 °C. Dry flash column chromatography was carried out on
Merck silica gel 60, particle size 40–63 µm, and reverse phase Fluka C18
silica gel 90. Thin-layer chromatography (TLC) was performed on silica
gel Merck Kieselgel 60 F254 plates and Merck Kieselgel RP-18 60 F254, and
visualized with UV (λmax 254 or 365 nm). UV–Vis spectra were recorded on Hitachi UV/VIS U-1900 and Shimadzu PC-160 spectrophotometers. 1H and 13C NMR spectra were acquired on an Agilent DD2
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8H, eCH2eCH3), 0.87 (m, 12H, CH3), −1.85 (s, 2H, 2 × NH). 13C NMR
(201 MHz, pyridine‑d5) δ 166.3, 165.6, 160.3, 159.5, 150.7, 140.6,
139.3, 136.5, 133.3, 132.6, 132.5, 132.3, 131.1, 130.6, 124.4, 123.6,
123.4, 123.3, 123.1, 122.8, 120.5, 119.7, 69.4, 66.0, 62.2, 31.4, 30.5,
26.9, 20.0, 14.4. FT-IR (KBr, νmax/cm−1): 3292 (NH), 2959, 2926,
2870, 1719, 1684, 1558, 1506, 1456, 1387, 1339, 1314, 1238, 1119,
1055, 1024, 993, 875, 760, 739, 669. HRMS (ESI) m/z found:
1224.5420, [M]+ C68H72N8O10S2 requires 1224.4813; 1225.6148, [M
+H]+ C68H73N8O10S2 requires 1225.4891; 1247.5799, [M+Na]+
C68H72N8O10S2Na requires 1247.4711. For HPLC purity, see supplementary information.

tissue culture flasks at 37 °C in a humidified atmosphere containing 5%
CO2 and were passaged 1:6 (HSC-3, HeLa) or 1:4 (CAL 27) twice a week
using a Trypsin-EDTA solution (UCSF). All media, penicillin-streptomycin solution, L-glutamine, FBS, Trypsin-EDTA, phosphate-buffered
saline (PBS), Dulbecco's phosphate-buffered saline (DPBS), were obtained from the UCSF Cell Culture Facility, San Francisco, USA. Photosensitizers were dissolved in dimethyl sulfoxide (DMSO, Sigma-Aldrich)
and subsequently diluted in DMEM (without FBS and phenol red) to
obtain the desired concentration of photosensitizer used in the experiments. The DMSO concentration in the final solution did not exceed
0.25%.

3.3. Singlet oxygen measurements and spectroscopic studies

3.5.2. Dark Toxicity
One day before the experiment, cells were seeded in 48-well plates
at a density 1.8 × 105 in 1 mL of medium (with FBS and phenol red)
and used at approximately 80% confluence. Subsequently, cells were
washed with PBS (1.0 mL) and 1 mL of medium without FBS and phenol
red, containing the photosensitizer at a given concentration, was added
to each well, except controls. The FBS-free media were used to avoid
binding of photosensitizers to serum proteins. After the 24 h incubation
at 37 °C, cells were washed with PBS, 1 mL of complete medium was
added to each well, and the cells were incubated for 24 h at 37 °C. Cell
viability was quantified by the Alamar Blue assay. Cells incubated either with medium alone or medium/0.25% DMSO served as controls.

Singlet oxygen generation by seco-porphyrazine 2 was measured in
DMF according to the methodology described previously and using the
indirect chemical method with DPBF [38,54,55]. 1,3-Diphenylisobenzofuran (DPBF) was used as a singlet oxygen chemical quencher
(Aldrich). Unsubstituted zinc phthalocyanine (ZnPc) with a known
singlet oxygen quantum yield (0.56 in DMF) was used as a reference
[56].
3.4. Liposome preparation
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), L-αphosphatidyl-DL-glycerol (chicken egg, PG) 1,2-dioleoyl-3-trimethylammonium-propane (chloride salt, DOTAP) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) were purchased from Avanti Polar
Lipids Inc. Four different liposome formulations were prepared by a
thin-film hydration method [32,46]. Briefly, appropriate amounts of
the lipid stock solutions in chloroform (POPC – 25 mg/mL, PG – 25 mg/
mL, DOPE – 25 mg/mL, DOTAP – 10 mg/mL) and the photosensitizer
(0.4 mg/mL) were placed in glass tubes, mixed and evaporated to
dryness using a rotary evaporator. Films formed on the bottom of glass
tubes were dried overnight in a vacuum oven at room temperature to
evaporate any remaining chloroform. Subsequently, the dried films
were hydrated with HEPES buffered saline (10 mM HEPES (N-(2-hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid)), 140 mM NaCl,
pH = 7.5), and dispersed by vortexing for 5–10 min. The resulting liposome suspensions were passed 21 times through polycarbonate
membranes with a pore diameter of 100 nm, using a syringe extruder
(Avanti Polar Lipids Inc) to obtain unilamellar liposomes with a uniform
size distribution. The molar ratios of ingredients in the final liposome
formulations were: (i) 2 (0.1), PG (2), POPC (8); (ii) 2 (0.1), DOTAP (2),
POPC (8); (iii) 2 (0.1), PG (2), DOPE (8); (iv) 2 (0.1), DOTAP (2), DOPE
(8). The liposome size was determined by dynamic light scattering
measurements using a Beckman Coulter N4 Plus Particle Size Analyzer
(see supplementary information 4.1). Samples were stored at 2–8 °C
under argon and were protected from light. The final concentration of
photosensitizer achieved in the liposome suspensions was 100 μM.
These suspensions were diluted with DME medium without FBS to
achieve appropriate concentration for biological activity evaluation on
cultured cells. Liposomes without photosensitizers were prepared as
controls.

3.5.3. Light-dependent toxicity
One day before the experiment CAL 27, HSC-3 or HeLa cells were
seeded in 48-well plates at a density 1.8 × 105 cells per well, respectively, in 1 mL of complete medium, and used at approximately 80%
confluence. Cells were washed with PBS (1 mL), and 1 mL of medium
without FBS and phenol red, containing a photosensitizer, was added to
each well, except controls. The cells were incubated for 24 h at 37 °C,
washed with PBS and irradiated for 20 min with light of wavelength
690 nm from a High Power LED Multi Chip Emitter (Roithner Lasertechnik
GmbH, 9.8 V). The light intensity at the surface of the plate was set to
3.0 mW/cm2 measured by a Thorlabs TM100A Optical Power Meter, and
the total light dose was 3.6 J/cm2. One plate from each experiment was
not exposed to light and served as a control. Directly after light exposure, medium without FBS and phenol red was replaced with 1 mL of
complete medium, and the cells were incubated for 24 h at 37 °C. Cell
viability was quantified by the Alamar Blue assay.
3.5.4. Cell Viability
Cell morphology was evaluated by Nikon TMS inverted phase-contrast microscopy at 100× magnification. The number of viable cells
used for the experiments was determined by the Trypan Blue exclusion
assay (Gibco-Invitrogen Corporation). Cell viability was quantified by a
modified Alamar Blue assay [58,59]. Briefly, 1.0 mL of 10% (v/v)
Alamar Blue dye in the appropriate complete medium was added to
each well. After incubation at 37 °C for 2–3 h, 200 µL of the supernatant
was assayed by measuring the absorbance at 570 nm and 600 nm. Cell
viability (as a percentage of control cells) was calculated according to
the formula:

3.5. Biological activity against cancer cell lines

Cell viability = [(A570

A 600) of test cells]

3.5.1. Cell Culture
Oral squamous cell carcinoma cell lines derived from the tongue
(CAL 27, HSC-3) were purchased from ATCC (CAL 27) or provided by
Dr. R. Kramer (University of California, San Francisco, UCSF, USA) (HSC3) [57]. Human cervical epithelial adenocarcinoma cells (HeLa) were
purchased from ATCC. Cells were cultured in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 10% (v/v) heat-inactivated fetal
bovine serum (FBS), penicillin (100 U/mL), streptomycin (100 µg/mL)
and L-glutamine (4 mM) (DMEM/10). Cells were incubated in T-25

3.5.5. Statistical analysis
Statistical analyses were performed with one-way analysis of variance ANOVA followed by Dunnett's multiple comparison test using
GraphPad Prism version 6.07 for Windows, GraphPad Software, San Diego
California, USA. The results were presented as the means ± SD from
experiments performed in triplicate. A probability value (p) of less than
0.05 was considered significantly different.

× 100/[(A570

7

A 600) of control cells].
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A new member of the seco-porphyrazine group, namely S-seco-Pz,
was obtained, and its physicochemical properties and photocytotoxicity
were examined. Heating a mixture of an aqueous alkaline solution of
sodium hydroxide and a solution of 22,23-bis[4-(3,5-dibutoxycarbonylphenoxy)butylsulfanyl]tribenzo[b,g,l]porphyrazinato magnesium(II) in dichloromethane resulted in the formation of novel S-secoPz. The optimization of the synthesis procedure resulted in a 34% yield
of the target macrocycle, following the biphasic system consisting of an
aqueous KMnO4 solution and Pz substrate in dichloromethane.
Physicochemical characterization of the S-seco-Pz was performed with
the use of NMR spectroscopy, UV–Vis spectroscopy, as well as mass
spectrometry. Singlet oxygen quantum yield generation measurements
following an indirect chemical method with 1,3-diphenylisobenzofuran
in DMF revealed that the novel S-seco-Pz efficiently mediates singlet
oxygen generation to a moderate extent (ΦΔ = 0.27), indicating a fivefold increase over the parent molecule.
The potential utility of S-seco-porphyrazine in photodynamic
therapy was assessed by measuring its photocytotoxicity in vitro on
three cell lines. The macrocycle was non-toxic in the dark (cell viability > 80%). After irradiation with 690 nm light, the calculated IC50
were 0.61, 0.18 and 4.1 µM for CAL 27, HSC-3 and HeLa cells, respectively. Four different liposomal compositions, two of them neutral,
one negatively and one positively charged were applied in the photocytotoxicity study. Overall, the cationic liposomes exhibited the best
efficiency, as the IC50 values were the lowest for CAL 27 and HeLa cells
(0.24 and 0.31 µM, respectively), while for HSC-3 the IC50 value was
slightly higher (0.25 µM), than those for the free Pz 2. However, the
cytotoxicity of Pz 2 in PG:POPC and PG:DOPE liposomes was much
lower than that of the the free compound. Thus, optimal liposome
compositions should be established for novel photosensitizers.
All these results indicate that the new seco-tribenzoporphyrazine
can be regarded as a potential photosensitizer for use in photodynamic
therapy of cancer, along with the developed cationic liposomal nanocarrier.
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